Metformin improves the angiogenic potential of human CD34(+) cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with diabetes mellitus (DM). To identify the most effective treatment for CVD, it is paramount to understand the mechanism behind cardioprotective therapies. Although metformin has been shown to redu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: Bakhashab, Sherin, Ahmed, Fahad W., Schulten, Hans-Juergen, Bashir, Ayat, Karim, Sajjad, Al-Malki, Abdulrahman L., Gari, Mamdooh A., Abuzenadah, Adel M., Chaudhary, Adeel G., Alqahtani, Mohammed H., Lary, Sahira, Ahmed, Farid, Weaver, Jolanta U.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748498/
https://ncbi.nlm.nih.gov/pubmed/26861446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0344-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados